Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term concurrent chemotherapy. Found 9 abstracts

Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head & neck. 2014 Dec;36(12):1677-84.   PMCID: PMC3972378
Martins RG, D'Amico TA, Loo BW, Pinder-Schenck M, Borghaei H, Chaft JE, Ganti AK, Kong FM, Kris MG, Lennes IT, Wood DE. The Management of Patients With Stage IIIA Non-Small Cell Lung Cancer With N2 Mediastinal Node Involvement. Journal of the National Comprehensive Cancer Network. 2012 May;10(5):599-613.   PMCID: not NIH funded
McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ, Expert Panel Radiation O. ACR APPROPRIATENESS CRITERIA (R) RETREATMENT OF RECURRENT HEAD AND NECK CANCER AFTER PRIOR DEFINITIVE RADIATION. International Journal of Radiation Oncology Biology Physics. 2011 Aug;80(5):1292-8.   PMCID: not NIH funded
Randall LM, Monk BJ, Moon J, Parker R, Al-Ghazi M, Wilczynski S, Fruehauf JP, Markman M, Burger RA. Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Group Study. Gynecologic Oncology. 2010 Dec;119(3):417-21.   PMCID: PMCID: PMC2978536 [Available on 2011/12/1]
Pfister DG, Ridge JA. Induction chemotherapy for larynx preservation: Patient selection or therapeutic effect?. JOURNAL OF CLINICAL ONCOLOGY. 2006 Feb;24(4):540-3.
Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. International Journal of Radiation Oncology Biology Physics. 2005 Jun;62(2):342-50.
Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. Journal of Clinical Oncology. 2005 Apr;23(10):2145-54.
Bradley J, Movsas B. Radiation esophagitis: Predictive factors and preventive strategies. Seminars in Radiation Oncology. 2004 Oct;14(4):280-6.
Forastiere AA, Pfister DG, Ang K, Brockstein B, Colevas AD, Ellenhorn J, Goepfert H, Hicks WL, Hong WK, Kies MS, Lydiatt W, McCaffrey T, Mittal BB, Ridge JA, Schuller DE, Shah JP, Spencer S, Trotti A, Urba S, Weymuller EA, Wheeler RH, Wolf GT. NCCN Practice Guidelines for head and neck cancers. Oncology-New York. 2000 Nov;14(11A):163-94.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term concurrent chemotherapy

concurrent chemotherapy radiotherapy carcinoma locally advanced head neck-cancer therapy cisplatin clinical-trials squamous-cell carcinoma In vitro assay radiation-therapy Reirradiation lymphoma pathology trial quality-of-life prediction mortality human papillomavirus (HPV) Salvage 1987 ylor sg-annals of thoracic surgery-v43-p87 postoperative radiation-therapy nasopharyngeal organ preservation randomized controlled-trial cell lung-cancer randomized phase-iii oral cavity esophagitis irradiation metaanalysis combination chemotherapy Chemoradiation induced injury amifostine extracapsular extension (ECE) unknown primary phase-iii randomized trial conventional fractionation induction chemotherapy phase- Cervical cancer survival vp-16-213 Unknown Primary Neoplasms cell-death phase-ii Head and Neck Neoplasms Male chemoradiotherapy glottic cancer emission-tomography nasopharyngeal carcinoma Papillomavirus Infections Female therapy oncology group prognostic-factors pelvic irradiation randomized-trial Radiation resistance thoracic radiation therapy 1993 wler wc-annals of thoracic surgery-v55-p986 chemoradiation sloan-kettering experience phase-iii trial Appropriateness criteria dosimetric predictors salvage surgery metabolism etoposide small-cell lung cancer carboplatin neoadjuvant therapy oncology-group 2nd primary head Oncology conformal radiotherapy endobronchial ultrasound Squamous Cell Carcinoma Neoplasm Proteins Age Factors Survival Analysis fractionation postoperative reirradiation tissue microarray iii low-dose paclitaxel Head-and-neck cancer intensification toxicity preoperative chemotherapy Biological Tumor Markers Tissue Array Analysis hydroxyurea cis-dichlorodiammineplatinum(ii) head
Last updated on Thursday, April 02, 2020